Pavle Repovic

1.9k total citations
52 papers, 975 citations indexed

About

Pavle Repovic is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Pavle Repovic has authored 52 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 12 papers in Oncology. Recurrent topics in Pavle Repovic's work include Multiple Sclerosis Research Studies (38 papers), Peripheral Neuropathies and Disorders (9 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Pavle Repovic is often cited by papers focused on Multiple Sclerosis Research Studies (38 papers), Peripheral Neuropathies and Disorders (9 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Pavle Repovic collaborates with scholars based in United States, Canada and Netherlands. Pavle Repovic's co-authors include Etty Benveniste, Nicholas J. Van Wagoner, Jae‐Wook Oh, James D. Bowen, Jop Mostert, Gary Cutter, Bernard M.J. Uitdehaag, Marcus Koch, Chulhee Choi and Kaihong Mi and has published in prestigious journals such as Journal of Neuroscience, Neurology and Oncogene.

In The Last Decade

Pavle Repovic

50 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavle Repovic United States 17 360 250 222 189 160 52 975
Sara Haghighi Sweden 15 497 1.4× 133 0.5× 315 1.4× 155 0.8× 267 1.7× 35 944
Nicholas J. Gutowski United Kingdom 20 190 0.5× 106 0.4× 381 1.7× 161 0.9× 129 0.8× 32 1.0k
Jacqueline M. Orian Australia 18 260 0.7× 110 0.4× 324 1.5× 139 0.7× 124 0.8× 45 978
Maddalena Ruggieri Italy 21 468 1.3× 132 0.5× 501 2.3× 228 1.2× 382 2.4× 55 1.4k
Sriram Ramanan United States 11 263 0.7× 111 0.4× 284 1.3× 322 1.7× 93 0.6× 18 1.1k
Yanyan Jiang United Kingdom 20 163 0.5× 288 1.2× 728 3.3× 206 1.1× 282 1.8× 29 1.5k
Kazumasa Okada Japan 17 364 1.0× 80 0.3× 186 0.8× 156 0.8× 485 3.0× 61 1.1k
Cheng‐Chih Hsiao Netherlands 19 186 0.5× 134 0.5× 491 2.2× 459 2.4× 56 0.3× 37 1.2k
Volker Siffrin Germany 22 586 1.6× 209 0.8× 434 2.0× 717 3.8× 152 0.9× 50 1.8k
Maria Staykova Australia 20 283 0.8× 257 1.0× 363 1.6× 785 4.2× 63 0.4× 37 1.5k

Countries citing papers authored by Pavle Repovic

Since Specialization
Citations

This map shows the geographic impact of Pavle Repovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavle Repovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavle Repovic more than expected).

Fields of papers citing papers by Pavle Repovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavle Repovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavle Repovic. The network helps show where Pavle Repovic may publish in the future.

Co-authorship network of co-authors of Pavle Repovic

This figure shows the co-authorship network connecting the top 25 collaborators of Pavle Repovic. A scholar is included among the top collaborators of Pavle Repovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavle Repovic. Pavle Repovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leavitt, Victoria M., Robert J. Fox, Jop Mostert, et al.. (2025). Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study. Multiple Sclerosis Journal. 31(7). 866–876. 1 indexed citations
2.
Spain, Rebecca, M. Mateo Paz Soldán, Mark S. Freedman, et al.. (2025). Lipoic Acid for Treatment of Progressive Multiple Sclerosis. Neurology. 106(1). e214454–e214454. 1 indexed citations
3.
Leavitt, Victoria M., Jop Mostert, Jacynthe Comtois, et al.. (2025). Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy. Journal of Neurology. 272(5). 338–338. 2 indexed citations
4.
Strijbis, Eva, Jop Mostert, Jacynthe Comtois, et al.. (2024). Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis. Neurology. 104(2). e210153–e210153. 2 indexed citations
5.
Koch, Marcus, Luís Brieva, Jop Mostert, et al.. (2023). Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset. Multiple Sclerosis Journal. 29(14). 1776–1785. 6 indexed citations
6.
Spain, Rebecca, Andrea Hildebrand, William D. Rooney, et al.. (2023). Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis. Frontiers in Neurology. 14. 1188124–1188124. 5 indexed citations
7.
Strijbis, Eva, Jop Mostert, Zoé L. E. van Kempen, et al.. (2023). Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(10). 792–799. 4 indexed citations
8.
Strijbis, Eva, Pavle Repovic, Jop Mostert, et al.. (2022). The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials. Multiple Sclerosis Journal. 28(10). 1606–1619. 6 indexed citations
9.
Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2021). MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 28(4). 561–572. 11 indexed citations
10.
Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2021). Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS. Multiple Sclerosis Journal. 28(8). 1286–1298. 3 indexed citations
11.
Weinstock‐Guttman, Bianca, Maria Pia Sormani, & Pavle Repovic. (2021). Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future Directions. International Journal of MS Care. 24(4). 184–188. 9 indexed citations
12.
Kamudoni, Paul, Jeffrey Johns, Karon F. Cook, et al.. (2021). Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 – Fatigue (MS) 8a. Multiple Sclerosis and Related Disorders. 54. 103117–103117. 16 indexed citations
13.
Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2021). Early first‐line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosis. European Journal of Neurology. 29(4). 1106–1116. 2 indexed citations
14.
15.
Yarnykh, Vasily L., et al.. (2018). Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction. American Journal of Neuroradiology. 39(4). 618–625. 28 indexed citations
16.
17.
18.
19.
20.
Wagoner, Nicholas J. Van, et al.. (2000). Oncostatin M Regulation of Interleukin‐6 Expression in Astrocytes. Journal of Neurochemistry. 75(2). 563–575. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Haghighi Breakdown of academic impact, for papers by Nicholas J. Gutowski Breakdown of academic impact, for papers by Jacqueline M. Orian Breakdown of academic impact, for papers by Maddalena Ruggieri Breakdown of academic impact, for papers by Sriram Ramanan Breakdown of academic impact, for papers by Yanyan Jiang Breakdown of academic impact, for papers by Kazumasa Okada Breakdown of academic impact, for papers by Cheng‐Chih Hsiao Breakdown of academic impact, for papers by Volker Siffrin Breakdown of academic impact, for papers by Maria Staykova
Rankless by CCL
2026